000 | 01728 a2200529 4500 | ||
---|---|---|---|
005 | 20250514182642.0 | ||
264 | 0 | _c20040709 | |
008 | 200407s 0 0 spa d | ||
022 | _a0210-0010 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGarcía Escrivà, A | |
245 | 0 | 0 |
_a[Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment]. _h[electronic resource] |
260 |
_bRevista de neurologia _c |
||
300 |
_a401-5 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAtrial Fibrillation _xclassification |
650 | 0 | 4 |
_aBrain Damage, Chronic _xepidemiology |
650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
650 | 0 | 4 |
_aCerebral Infarction _xdrug therapy |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aComorbidity |
650 | 0 | 4 | _aDrug Evaluation |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrinolytic Agents _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIntracranial Embolism _xdrug therapy |
650 | 0 | 4 |
_aIschemic Attack, Transient _xepidemiology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSpain _xepidemiology |
650 | 0 | 4 |
_aStroke _xclassification |
700 | 1 | _aLópez Hernández, N | |
700 | 1 | _aHernández Lorido, R | |
700 | 1 | _aOliver Navarrete, C | |
700 | 1 | _aBustos, S | |
700 | 1 | _aCarneado Ruiz, J | |
700 | 1 | _aGracia Fleta, F | |
700 | 1 | _aMoltó Jordá, J M | |
773 | 0 |
_tRevista de neurologia _gvol. 38 _gno. 5 _gp. 401-5 |
|
999 |
_c14747438 _d14747438 |